Ret Proto-Oncogene anticorps (AA 881-930)
-
- Antigène Voir toutes Ret Proto-Oncogene (RET) Anticorps
- Ret Proto-Oncogene (RET)
-
Épitope
- AA 881-930
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Ret Proto-Oncogene est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)
- Specificité
- Ret (Ab-905) Antibody detects endogenous levels of total Ret protein.
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide from human RET (aa881-930).
Type of Immunogen: Synthetic peptide - Isotype
- IgG
- Top Product
- Discover our top product RET Anticorps primaire
-
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reactivité: Humain IHC, StM Hôte: Souris Monoclonal RET-2795 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibodyRET Reactivité: Humain WB, PLA Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibodyRET Reactivité: Humain ELISA, Coat Hôte: Souris Monoclonal RET-2663 unconjugated
anti-Ret Proto-Oncogene (RET) antibodyRET Reactivité: Humain WB Hôte: Lapin Monoclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibodyRET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB00705 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibodyRET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB01561 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 361-458) antibodyRET Reactivité: Humain WB, ELISA, PLA Hôte: Souris Monoclonal 1A5 unconjugated
anti-Ret Proto-Oncogene (RET) (C-Term) antibodyRET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (pTyr1062) antibodyRET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 29-300) antibodyRET Reactivité: Humain WB, IHC, IF Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Approved: IF (1:100 - 1:500), IHC, IHC-P, Peptide-ELISA (1:1000), WB (1:500 - 1:1000)
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C.
-
- Antigène
- Ret Proto-Oncogene (RET)
- Autre désignation
- RET (RET Produits)
- Synonymes
- anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret
- Sujet
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 - ID gène
- 5979
- UniProt
- P07949
- Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-
